Percent who seroconverted (anti-rota serum IgA, 2 months post dose 2) [clinicaltrials_resource:ce5f3c20bb2c57a0f211f9eed5507c3d]
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
Percent who seroconverted (anti-rota serum IgA, 2 months post dose 2) [clinicaltrials_resource:ce5f3c20bb2c57a0f211f9eed5507c3d]
Bio2RDF identifier
ce5f3c20bb2c57a0f211f9eed5507c3d
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:ce5f3c20bb2c57a0f211f9eed5507c3d
measure [clinicaltrials_vocabulary:measure]
Percent who seroconverted (anti-rota serum IgA, 2 months post dose 2)
identifier
clinicaltrials_resource:ce5f3c20bb2c57a0f211f9eed5507c3d
title
Percent who seroconverted (anti-rota serum IgA, 2 months post dose 2)
@en
type
label
Percent who seroconverted (ant ...... f3c20bb2c57a0f211f9eed5507c3d]
@en